These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 23745791)
1. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies. Xia W; Shi R; Zheng WL; Ma WL Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791 [TBL] [Abstract][Full Text] [Related]
2. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis. Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262 [TBL] [Abstract][Full Text] [Related]
4. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis. Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients. Zhu CL; Huang Q; Liu CH; Xie F Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308 [TBL] [Abstract][Full Text] [Related]
6. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis. Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350 [TBL] [Abstract][Full Text] [Related]
7. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis. Wang B; Zhu JM; Fan YG; Feng CC; Chen GM; Chen H; Pan HF; Ye DQ Gene; 2013 Sep; 527(1):95-101. PubMed ID: 23747396 [TBL] [Abstract][Full Text] [Related]
8. CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis. Gyu Song G; Ho Lee Y Immunol Invest; 2013; 42(5):409-22. PubMed ID: 23802171 [TBL] [Abstract][Full Text] [Related]
9. Association between the cytotoxic T-lymphocyte antigen 4-318C/T polymorphism and malignant tumor risk. Li T; Wang C; Ren Z; Ji YI; Xu C; Xiao B; Liu M Biomed Rep; 2016 Jul; 5(1):93-100. PubMed ID: 27347411 [TBL] [Abstract][Full Text] [Related]
10. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies. Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045 [TBL] [Abstract][Full Text] [Related]
11. Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis. Chen Z; Fei M; Fu D; Zhang L; Ma Y; Wang Y; Zhang F; Xia Q; Wang X Gene; 2013 Mar; 516(2):263-70. PubMed ID: 23261825 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T‑lymphocyte-associated antigen‑4 polymorphisms and susceptibility to cervical cancer: a meta‑analysis. Qiu H; Tang W; Yin P; Cheng F; Wang L Mol Med Rep; 2013 Dec; 8(6):1785-94. PubMed ID: 24126947 [TBL] [Abstract][Full Text] [Related]
13. Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis. Dai Z; Feng C; Zhang W; Liu J; Cao X; Zhang H; Liu Y; Wang M; Liu X; Dai Z Ann Hematol; 2016 Oct; 95(10):1685-94. PubMed ID: 27498821 [TBL] [Abstract][Full Text] [Related]
14. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever. Gunesacar R; Erken E; Dinkci S Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220 [TBL] [Abstract][Full Text] [Related]
15. Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis. Hu Y; Xu K; Jiang L; Zhang L; Shi H; Cui D Genet Test Mol Biomarkers; 2018 Apr; 22(4):224-236. PubMed ID: 29461867 [TBL] [Abstract][Full Text] [Related]
16. -1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): a comprehensive meta-analysis. Liu J; Zhang H Hum Immunol; 2013 Mar; 74(3):341-7. PubMed ID: 23261408 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of the association between CTLA-4 +49 A/G, -318 C/T, and IL-1 polymorphisms and susceptibility to cervical cancer. Lee YH; Song GG Neoplasma; 2014; 61(4):481-90. PubMed ID: 24712845 [TBL] [Abstract][Full Text] [Related]
18. Relationship between cytotoxic T-lymphocyte antigen 4 -318C/T (rs5742909) gene polymorphism and the risk of acute rejection in renal transplantation. Yang CH; Chen XX; Chen L; Zheng DH; Liu QS; Xie WF; Zhou TB; Drummen GPC Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28449371 [TBL] [Abstract][Full Text] [Related]
19. Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas. Fan C; Zhao X; Xu Z Tumour Biol; 2015 Jan; 36(1):227-31. PubMed ID: 25230787 [TBL] [Abstract][Full Text] [Related]
20. CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and systemic lupus erythematosus: a meta-analysis. Zhu Y; Wang J; Feng X Crit Rev Eukaryot Gene Expr; 2014; 24(2):89-100. PubMed ID: 24940764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]